Merck expects over $5 billion commercial opportunity from Cidara's flu drug
Cidara TherapeuticsCidara Therapeutics(US:CDTX) Reuters·2025-11-17 13:34

公司合作与财务预期 - 默克公司预计与Cidara Therapeutics实验性流感药物相关的非风险调整后商业机会将超过50亿美元 [1]